(Date:7/2/2008)...e of two distinct drugs on separat...ly 2 /- Boston Scientific,C...U.S. Food and Drug,Administration (FDA) has approv...t System for the treatment of coronary artery dise...TM) V Everolimus-Eluting Coronary,Stent System man...
(Date:7/2/2008)...growing line of injectable ...wswire/ -- Bioniche Pharma, a leading,developer an...unced today,the acquisition of Baxter Healthcare C... ENLON(R) (edrophonium chloride injection, USP) 10...chloride, USP and atropine sulfate, USP) Injec...
(Date:7/2/2008)... Technology Receive Funding, From Allied Minds to ...of Aliquots, BOSTO... investment,corporation specializing in early stag...,s Office of Technology Development, and Northeast... Instruments, LLC, a new,spin-out focused on the e...
(Date:7/2/2008)...ent R2 levels as a possible pre...RNewswire-FirstCall/ - Lorus Therapeutics Inc. (TS... a biopharmaceutical company,specializing in the r... and,technologies for the management of cancer, to...ity (OSU) clinical team of a paper entitled "Phase...
Breaking Biology Technology:Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5... Madison, Wis. - When Milwaukee-based coffee cha...ine presence, the company chose an emerging tool t...ording to Tom Pionek, the company,s technology and...k Coffee an ability to communicate with customers ...itional forms of communications. The company uses ...
... MILWAUKEE - A group of business and technology ...erve $2.6 million in pledged state funds for the ... to increase collaboration between academic resear...in. , ,The funding was previously approved the Joi...rsed by the Doyle administration, but is in danger...
... Waukesha, Wis. - ProHealth Care , a not-for-pr...unty, has deployed an application delivery system ... network. , ,ProHealthCare selected the system to ...ime across its network of more than 700 physicians...cs, home health care services. , ,System architect...
... Brown Deer, Wis. - Catalyst International, Inc...dent and CEO. , ,Eleftheriou, with more than 30 ye...ctor, had a long career with Control Data, where h...ion business. He has served assignments in North A... East. , ,Since 2002, Eleftheriou has served on th...
Other Biology Technology:Business blogs increase customer interactions 2Business blogs increase customer interactions 3Business blogs increase customer interactions 4Business blogs increase customer interactions 5Budget axe could cut SE Wisconsin tech alliance funding 2Budget axe could cut SE Wisconsin tech alliance funding 3HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems.
Human CXCL14/BRAK Affinity Purified Polyclonal Ab
mIGSF4A Aff Pur PAb
Human Serpin B5/Maspin Affinity Purified Polyclonal Ab
Biology Products: